Biogen CEO Michel Vounatsos' 2020 pay rises 3% to $19M
Biogen reports 2020 executive compensation
By ExecPay News
Published: April 23, 2021
Biogen reported fiscal year 2020 executive compensation information on April 23, 2021.
In 2020, six Biogen executives received on average a compensation package of $8.5M, a 15% increase compared to previous year.
Average pay of disclosed executives at Biogen
Michel Vounatsos, Chief Executive Officer, received $19M in total, which increased by 3% compared to 2019. 74% of Vounatsos' compensation, or $14M, was in stock awards. Vounatsos also received $264K of change in pension value and nonqualified deferred compensation earnings, $2.6M in non-equity incentive plan, $1.5M in salary, as well as $455K in other compensation.
For fiscal year 2020, the median employee pay was $155,378 at Biogen. Therefore, the ratio of Michel Vounatsos' pay to the median employee pay was 120 to one.
Jeffrey D. Capello, Chief Financial Officer, received a compensation package of $9.2M, which increased by 59% compared to previous year. 50% of the compensation package, or $4.6M, was in other compensation.
Michael R. McDonnell, Chief Financial Officer, earned $6.6M in 2020.
Alfred W. Sandrock, Jr, Executive Vice President, Research & Development, received $6.2M in 2020, which increases by 17% compared to 2019.
Susan H. Alexander, Chief Legal Officer, earned $5.5M in 2020, which is about the same as previous year.
Chirfi Guindo, Executive Vice President, Global Product Strategy and Commercialization, received $5.1M in 2020, which increases by 9% compared to 2019.
Related executives
Michel Vounatsos
Biogen
Chief Executive Officer
Michael McDonnell
Biogen
Chief Financial Officer
Alfred Sandrock
Biogen
Executive Vice President, Research & Development
Susan Alexander
Biogen
Chief Legal Officer
Chirfi Guindo
Biogen
Executive Vice President, Global Product Strategy and Commercialization
Jeffrey Capello
Biogen
Chief Financial Officer
You may also like
Source: SEC filing on April 23, 2021.